Related Experiment Video
Updated: Jan 20, 2026

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
Published on: July 7, 2016
Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue
Krishna Das1,2, Carles Urbiola1,2, Bart Spiesschaert1,2,3
1Division of Virology, Medical University of Innsbruck, Innsbruck, Austria.
Abstract:
In addition of being directly tumoricidal, oncolytic viruses have emerged as potent partners for established and investigational immunotherapies due to their immune-stimulatory effects. The shifting focus on virus-mediated immune modulation calls for a comprehensive analysis of the tumor microenvironment (TME) and the factors orchestrating the antiviral and antitumor immune response. The oncolytic VSV-GP studied in our lab is a safe and potent antitumor agent with a fast replication cycle and killing of a broad range of different cancer types. It induces a robust local inflammatory conversion of the TME and drives a strong adaptive immune response toward the tumor. Here we present our multidisciplinary approach to study VSV-GP treatment effects in tumors by assessing both immune cells (tumor-infiltrating lymphocytes and tumor-associated macrophages) and immune-regulatory factors (cytokines) as well as characterizing immune signatures using an immune-targeted NanoString gene expression system.
Insights
Oncolytic virus VSV-GP effectively targets tumors and stimulates the immune system. This study analyzes its impact on the tumor microenvironment, revealing its potential in cancer immunotherapy.
Area of Science:
- Immunology
- Virology
- Oncology
Background:
- Oncolytic viruses are promising cancer immunotherapies due to their tumor-killing and immune-stimulating properties.
- Understanding the tumor microenvironment (TME) is crucial for optimizing antiviral and antitumor immune responses.
- VSV-GP is an oncolytic virus with a rapid replication cycle, broad-spectrum anticancer activity, and ability to induce inflammation.
Purpose of the Study:
- To comprehensively analyze the effects of VSV-GP oncolytic virus treatment in the tumor microenvironment.
- To investigate the modulation of immune cells and immune-regulatory factors by VSV-GP.
- To characterize immune signatures induced by VSV-GP using gene expression profiling.
Main Methods:
- Utilized a multidisciplinary approach to study VSV-GP treatment effects in tumors.
- Assessed tumor-infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs).
- Analyzed immune-regulatory factors, including cytokines.
- Employed an immune-targeted NanoString gene expression system to characterize immune signatures.
Main Results:
- VSV-GP demonstrated potent direct tumoricidal activity.
- Treatment with VSV-GP induced a robust inflammatory conversion of the tumor microenvironment.
- A strong adaptive immune response towards the tumor was observed following VSV-GP treatment.
Conclusions:
- VSV-GP is a safe and effective oncolytic virus with significant potential in cancer immunotherapy.
- VSV-GP effectively modulates the tumor microenvironment and enhances anti-tumor immunity.
- Further research into VSV-GP-mediated immune modulation can optimize combination therapies.
Related Concept Videos
07:12Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
07:16Thermal Ablation for the Treatment of Abdominal Tumors
10:58Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
11:12Tissue Engineering of a Human 3D in vitro Tumor Test System
06:32Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
04:34Surgical Treatment of an Endolymphatic Sac Tumor

